The Second Annual Houston Shock Symposium 2019

The Houston Shock Symposium is a dedicated cardiogenic shock symposium that encompasses interventionalists, advanced heart failure cardiologists, cardiothoracic surgeons, cardiac physiologists, cardiologists, critical care physicians, and engineers. It is our aim to have world renowned experts in this field to share and advance knowledge, expertise, and vision to save lives and reduce shock’s unacceptable high mortality rate.

Recent Cardiology Headlines

CREOLE Study: Drug Combos with Amlodipine Reduce Hypertension in sub-Saharan African Patients

Drug Combos with Amlodipine Reduce Hypertension in sub-Saharan African Patients: CREOLE Study

Two blood pressure-lowering combination therapies that included amlodipine were more effective at lowering hypertension in patients in sub-Saharan Africa, new research from the American...

New Prevention Guidelines Emphasize Lifestyle Changes, Discourage Daily Aspirin

New prevention guidelines released at the American College of Cardiology Annual Scientific Session in New Orleans include information on heart-healthy diets, exercise regimens, and...
Apixaban Plus P2Y12 Inhibitor and No Aspirin Safe in Two Patient Groups

Apixaban Plus Clopidogrel and No Aspirin Safe in Two Patient Groups

The combination of apixaban and clopidogrel was associated with a reduced risk for bleeding and hospitalization in patients with both atrial fibrillation (AFib) and...
TAVR as Good as Surgery for Low-surgical-risk Patients

TAVR as Good as Surgery for Low-surgical-risk Patients

The use of transcatheter aortic valve replacement (TAVR) with a novel self-expanding aortic valve was shown to be noninferior to surgical aortic valve replacement...
click me